z-logo
Premium
High‐throughput analysis revealed the unique immunoglobulin gene rearrangements in plasmacytoma‐like post‐transplant lymphoproliferative disorder
Author(s) -
Hoshino Akihiro,
Nishimura Akira,
Naruto Takuya,
Okano Tsubasa,
Matsumoto Kazuaki,
Okamoto Keisuke,
Shintaku Hiroshi,
Tokoro Shown,
Okamoto Hiroyuki,
Wada Taizo,
Takagi Masatoshi,
Imai Kohsuke,
Kanegane Hirokazu,
Morio Tomohiro
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16583
Subject(s) - plasma cell , multiple myeloma , plasmacytoma , lymph node , pathology , lymphoproliferative disorders , biology , antibody , medicine , immunology , cancer research , lymphoma
Jakovljevic G, Gasparov S, et al. Mast-cell sarcoma of the tibia. J Clin Pathol. 2007;60:424–5. 9. Krauth MT, Fodinger M, Rebuzzi L, Greul R, Chott A, Valent P. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Haematologica. 2007;92:e126–29. 10. Bugalia A, Abraham A, Balasubramanian P, Srivastava A, Nair S. Mast cell sarcoma of the small intestine: a case report. J Clin Pathol. 2011;64:1035–7. 11. Ma HB, Xu X, Liu WP, Chang H, Zeng F, Wang YC. Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol. 2011;94:491–4. 12. Auquit-Auckbur I, Lazar C, Deneuve S, Guillemet C, Cordel N, Blanchard F, et al. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol. 2012;36:779–82. 13. Falleti J, Borgia L, Lalinga AV, de Cecio R, Natella V, Patitucci G, et al. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis? Pathol Res Pract. 2012;208:683–6. 14. Georgin-Lavialle S, Aguilar C, Guieze R, Lhermitte L, Bruneau J, Fraitag S, et al. Mast cell sarcoma: a rare and aggressive entity–report of two cases and review of the literature. J Clin Oncol. 2013;31:e90–7. 15. Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, et al. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol. 2013;26:533–43. 16. Kim YS, Wu H, Pawlowska AB, BautistaQuach MA, Huang Q, Gaal K, et al. Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm. Am J Surg Pathol. 2013;37:453–8. 17. Bautista-Quach MA, Booth CL, Kheradpour A, Zuppan CW, Rowsell EH, Weiss L, et al. Mast cell sarcoma in an infant: a case report and review of the literature. J Pediatr Hematol Oncol. 2013;35:315–20. 18. Schwaab J, Horny HP, Jonescheit J, Metzgeroth G, Schafhausen P, Gaiser T, et al. Mast cell sarcoma mimicking metastatic colon carcinoma. Ann Hematol. 2014;93:1067–9. 19. He F, Horny HP, Boone J, Raza A, Griffith M, Hurley P, et al. Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis. Leuk Lymphoma. 2017;58:1515–7. 20. Yamashita A, Saito T, Akaike K, Arakawa A, Yoshida A, Kikuchi K, et al. Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation. Virchows Arch. 2017;470:583–8. 21. Ravanpay AC, Fromm JR, Edlefsen KL, Martin P, Chesnut R. The first report of human primary thoracic spine mast cell sarcoma: a case report. Clin Neuropathol. 2018;37:28–35. 22. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–25. 23. Valent, P Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematology Am Soc Hematol Educ Program. 2015;2015:98–105.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom